These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 6588051

  • 21. Induction of the regulatory subunit of type I adenosine cyclic 3':5'-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells.
    Liu AY, Chan T, Chen KY.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4579-87. PubMed ID: 6272981
    [Abstract] [Full Text] [Related]

  • 22. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
    Kim SN, Kim SG, Park SD, Cho-Chung YS, Hong SH.
    J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
    [Abstract] [Full Text] [Related]

  • 23. Cyclic adenosine 3':5'-monophosphate-dependent protein phosphorylation and the control of leukemia L1210 cell growth.
    Mednieks MI, Jungmann RA, DeWys WD.
    Cancer Res; 1982 Jul; 42(7):2742-7. PubMed ID: 6282449
    [Abstract] [Full Text] [Related]

  • 24. Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin.
    Hemmi H, Breitman TR.
    Jpn J Cancer Res; 1985 May; 76(5):345-51. PubMed ID: 2989063
    [Abstract] [Full Text] [Related]

  • 25. Increased glucocorticoid receptor concentration in macrophage differentiation of myeloid leukemia cells with 12-O-tetradecanoylphorbol-13-acetate.
    Hirai H, Murakami T, Urabe A, Takaku F.
    Cancer Res; 1985 Jun; 45(6):2456-61. PubMed ID: 3857120
    [Abstract] [Full Text] [Related]

  • 26. Interactions between cyclic AMP- and phorbol ester-dependent phosphorylation systems in S49 mouse lymphoma cells.
    Kiss Z, Steinberg RA.
    J Cell Physiol; 1985 Nov; 125(2):200-6. PubMed ID: 2997237
    [Abstract] [Full Text] [Related]

  • 27. ICAT as a potential enhancer of monocytic differentiation: implications from the comparative proteome analysis of the HL60 cell line stimulated by all-trans retinoic acid and NSC67657.
    Wang W, Zhang X, Deng K, Huang S, Mao X, Fu Y, Yi Z, Yan Y, Qiu Z.
    Cell Biochem Funct; 2009 Aug; 27(6):329-37. PubMed ID: 19569129
    [Abstract] [Full Text] [Related]

  • 28. Activation of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in H35 hepatoma and Chinese hamster ovary cells by a phorbol ester tumor promoter.
    Byus CV, Trevillyan JM, Cavit LJ, Fletcher WH.
    Cancer Res; 1983 Jul; 43(7):3321-6. PubMed ID: 6303580
    [Abstract] [Full Text] [Related]

  • 29. B16 mouse melanoma cells selected for resistance to cyclic AMP-mediated growth inhibition are cross-resistant to retinoic acid-induced growth inhibition.
    Niles RM, Loewy B.
    J Cell Physiol; 1991 Apr; 147(1):176-81. PubMed ID: 1645360
    [Abstract] [Full Text] [Related]

  • 30. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J, McQueen T, Engel H, Andreeff M, Robertson KA, Collins SJ, Malavasi F, Mehta K.
    Cancer Res; 1994 Apr 01; 54(7):1746-52. PubMed ID: 7511050
    [Abstract] [Full Text] [Related]

  • 31. Na+/H+ antiporter gene expression increases during retinoic acid-induced granulocytic differentiation of HL60 cells.
    Rao GN, Sardet C, Pouysségur J, Berk BC.
    J Cell Physiol; 1992 May 01; 151(2):361-6. PubMed ID: 1315322
    [Abstract] [Full Text] [Related]

  • 32. New facts and speculations on human myeloid leukemias.
    Breitman TR, Gallo RC.
    Blood Cells; 1981 May 01; 7(1):79-89. PubMed ID: 6964818
    [Abstract] [Full Text] [Related]

  • 33. Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
    Takahashi N, Breitman TR.
    Arch Biochem Biophys; 1994 Oct 01; 314(1):82-9. PubMed ID: 7944409
    [Abstract] [Full Text] [Related]

  • 34. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
    Matsumoto E, Hatanaka M, Bohgaki M, Maeda S.
    Kobe J Med Sci; 2006 Oct 01; 52(6):181-94. PubMed ID: 17329956
    [Abstract] [Full Text] [Related]

  • 35. [Changes of fibrinolytic activity of human HL60 acute leukemia cells responses to chemically induced differentiation].
    Ghezzo F, Palumbo A, Pegoraro L.
    Boll Soc Ital Biol Sper; 1980 Jul 15; 56(13):1355-9. PubMed ID: 6934784
    [Abstract] [Full Text] [Related]

  • 36. Effect of tumor promoters on the activity of cyclic adenosine 3':5'-monophosphate-dependent and -independent protein kinases from mouse epidermis.
    Murray AW, Froscio M.
    Cancer Res; 1977 May 15; 37(5):1360-3. PubMed ID: 192448
    [Abstract] [Full Text] [Related]

  • 37. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
    Taimi M, Breitman TR.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):432-6. PubMed ID: 9125196
    [Abstract] [Full Text] [Related]

  • 38. Regulation of the laminin beta 1 (LAMB1), retinoic acid receptor beta, and bone morphogenetic protein 2 genes in mutant F9 teratocarcinoma cell lines partially deficient in cyclic AMP-dependent protein kinase activity.
    Shen J, Li C, Gudas LJ.
    Cell Growth Differ; 1997 Dec 17; 8(12):1297-304. PubMed ID: 9419418
    [Abstract] [Full Text] [Related]

  • 39. Cyclic adenosine 3':5'-monophosphate-dependent and -independent protein kinase in acute myeloblastic leukemia.
    Elias L, Li AP, Longmire J.
    Cancer Res; 1981 Jun 17; 41(6):2182-8. PubMed ID: 6263462
    [Abstract] [Full Text] [Related]

  • 40. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.